Skip to main content

Imaging the Tumor Antioxidant Response with [18F]FSPG PET

  • Protocol
  • First Online:
Positron Emission Tomography

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2729))

  • 617 Accesses

Abstract

(4S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid ([18F]FSPG) is a flourine-18 labeled glutamate analog that enables the noninvasive in vivo imaging of cellular redox status. [18F]FSPG is transported across the cell membrane by the cystine/glutamate antiporter, system xc, whose expression is upregulated in multiple cancer types. The requirement of cystine for the biosynthesis of glutathione, a major antioxidant, connects [18F]FSPG tissue retention to the intracellular redox response via system xc activity. We herein describe the use of [18F]FSPG positron emission tomography (PET) to image the tumor antioxidant response and highlight key methodological considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science 368(6487). https://doi.org/10.1126/science.aaw5473

  2. Liu JY, Xia XJ, Huang P (2020) xCT: a critical molecule that links cancer metabolism to redox signaling. Mol Ther 28(11):2358–2366. https://doi.org/10.1016/j.ymthe.2020.08.021

    Article  CAS  Google Scholar 

  3. Oyama N, Akino H, Kanamaru H, Suzuki Y, Muramoto S, Yonekura Y, Sadato N, Yamamoto K, Okada K (2002) 11C-acetate PET imaging of prostate cancer. J Nucl Med 43(2):181–186

    CAS  Google Scholar 

  4. Qu W, Oya S, Lieberman BP, Ploessl K, Wang L, Wise DR, Divgi CR, Chodosh LA, Thompson CB, Kung HF (2012) Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors. J Nucl Med 53(1):98–105. https://doi.org/10.2967/jnumed.111.093831

    Article  CAS  Google Scholar 

  5. Farsad M, Schiavina R, Castellucci P, Nanni C, Corti B, Martorana G, Canini R, Grigioni W, Boschi S, Marengo M, Pettinato C, Salizzoni E, Monetti N, Franchi R, Fanti S (2005) Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 46(10):1642–1649

    CAS  Google Scholar 

  6. Koglin N, Mueller A, Berndt M, Schmitt-Willich H, Toschi L, Stephens AW, Gekeler V, Friebe M, Dinkelborg LM (2011) Specific PET imaging of xC- transporter activity using a (1)(8)F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism. Clin Cancer Res 17(18):6000–6011. https://doi.org/10.1158/1078-0432.CCR-11-0687

    Article  CAS  Google Scholar 

  7. McCormick PN, Greenwood HE, Glaser M, Maddocks ODK, Gendron T, Sander K, Gowrishankar G, Hoehne A, Zhang T, Shuhendler AJ, Lewis DY, Berndt M, Koglin N, Lythgoe MF, Gambhir SS, Arstad E, Witney TH (2019) Assessment of tumor redox status through (S)-4-(3-[F-18] fluoropropyl)-L-glutamic acid PET imaging of system x(c)(-) activity. Cancer Res 79(4):853–863. https://doi.org/10.1158/0008-5472.Can-18-2634

    Article  CAS  Google Scholar 

  8. Greenwood HE, McCormick PN, Gendron T, Glaser M, Pereira R, Maddocks ODK, Sander K, Zhang T, Koglin N, Lythgoe MF, Arstad E, Hochhauser D, Witney TH (2019) Measurement of tumor antioxidant capacity and prediction of chemotherapy resistance in preclinical models of ovarian cancer by positron emission tomography. Clin Cancer Res 25(8):2471–2482. https://doi.org/10.1158/1078-0432.CCR-18-3423

    Article  Google Scholar 

  9. Park SY, Na SJ, Kumar M, Mosci C, Wardak M, Koglin N, Bullich S, Mueller A, Berndt M, Stephens AW, Cho YM, Ahn H, Chae SY, Kim HO, Moon DH, Gambhir SS, Mittra ES (2020) Clinical evaluation of (4S)-4-(3-[(18)F]Fluoropropyl)-L-glutamate ((18)F-FSPG) for PET/CT imaging in patients with newly diagnosed and recurrent prostate cancer. Clin Cancer Res 26(20):5380–5387. https://doi.org/10.1158/1078-0432.CCR-20-0644

    Article  CAS  Google Scholar 

  10. Kavanaugh G, Williams J, Morris AS, Nickels ML, Walker R, Koglin N, Stephens AW, Washington MK, Geevarghese SK, Liu Q, Ayers D, Shyr Y, Manning HC (2016) Utility of [(18)F]FSPG PET to image hepatocellular carcinoma: first clinical evaluation in a US population. Mol Imaging Biol 18(6):924–934. https://doi.org/10.1007/s11307-016-1007-0

    Article  CAS  Google Scholar 

  11. Magarik MA, Walker RC, Gilbert J, Manning HC, Massion PP (2018) Intracardiac metastases detected by 18F-FSPG PET/CT. Clin Nucl Med 43(1):28–30. https://doi.org/10.1097/RLU.0000000000001883

    Article  Google Scholar 

  12. Mittra ES, Koglin N, Mosci C, Kumar M, Hoehne A, Keu KV, Iagaru AH, Mueller A, Berndt M, Bullich S, Friebe M, Schmitt-Willich H, Gekeler V, Fels LM, Bacher-Stier C, Moon DH, Chin FT, Stephens AW, Dinkelborg LM, Gambhir SS (2016) Pilot preclinical and clinical evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT imaging of intracranial malignancies. PLoS One 11(2):e0148628. https://doi.org/10.1371/journal.pone.0148628

    Article  CAS  Google Scholar 

  13. Edwards R, Greenwood H, Witney T (2020) Robust and facile automated radiosynthesis of [18F]FSPG on the GE FASTlab. https://doi.org/10.26434/chemrxiv.13434143.v2

  14. Witney TH, Lewis DY (2019) Imaging cancer metabolism with positron emission tomography (PET). Methods Mol Biol 1928:29–44. https://doi.org/10.1007/978-1-4939-9027-6_2

    Article  CAS  Google Scholar 

  15. Greenwood HE, Nyitrai Z, Mocsai G, Hobor S, Witney TH (2020) High-throughput PET/CT imaging using a multiple-mouse imaging system. J Nucl Med 61(2):292–297. https://doi.org/10.2967/jnumed.119.228692

    Article  CAS  Google Scholar 

  16. Gengenbacher N, Singhal M, Augustin HG (2017) Preclinical mouse solid tumour models: status quo, challenges and perspectives. Nat Rev Cancer 17(12):751–765. https://doi.org/10.1038/nrc.2017.92

    Article  CAS  Google Scholar 

  17. Golubeva Y, Rogers K (2009) Collection and preparation of rodent tissue samples for histopathological and molecular studies in carcinogenesis. Methods Mol Biol 511:3–60. https://doi.org/10.1007/978-1-59745-447-6_1

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy H. Witney .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Timmermand, O.V., Witney, T.H. (2024). Imaging the Tumor Antioxidant Response with [18F]FSPG PET. In: Witney, T.H., Shuhendler, A.J. (eds) Positron Emission Tomography. Methods in Molecular Biology, vol 2729. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3499-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-3499-8_14

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-3498-1

  • Online ISBN: 978-1-0716-3499-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics